Comparison
Caffeine vs Theacrine
Caffeine
The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. A competitive adenosine receptor antagonist that lifts the brake on dopamine and norepinephrine signalling. The canonical pairing is 100 mg caffeine + 200 mg L-theanine for clean focus without the jitter.
Theacrine
Methylated purine alkaloid related to caffeine. Slower onset, longer duration, no tolerance.
| Field | Caffeine | Theacrine |
|---|---|---|
| Category | stimulant | stimulant |
| Dose range | 50–400mg | 100–300mg |
| Half-life | 5h | 17h |
| Onset | 30min | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 25000 | 50 |
The comparison in plain English
Auto-generated from dataCaffeine and Theacrine are both in the stimulant category respectively. Caffeine The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. Theacrine Methylated purine alkaloid related to caffeine.
Bottom line
Caffeine (evidence A, safety 4/5) has a weaker evidence base than Theacrine (evidence B, safety 4/5). Caffeine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Caffeine if
Caffeine is the better fit when your goal aligns with its mechanism (Competitively blocks adenosine A1 and A2A receptors) and the dose range (50–400mg) suits your protocol. Half-life is 5h.
Choose Theacrine if
Theacrine is the better fit when your goal aligns with its mechanism (Adenosine A1 and A2A receptor antagonist with the same mechanism as caffeine, but with weak dopamine reuptake inhibition added) and the dose range (100–300mg) suits your protocol. Half-life is 17h.